...tools. Trinity’s suite of out-of-the-box, configurable and fully customized dashboards and business intelligence reporting services enable life sciences companies to democratize their data and share insights consistently and swiftly throughout...
Experts at Trinity Life Sciences interact with the inner workings of pharma from many perspectives as they engage with teams across life sciences organizations. A common observation is that teams...
While the vision and goal of patient centricity are clear, today’s leading life science companies are grappling with the complexities of execution: How to take the “idea” of patient centricity...
Virtual How Thank you for completing this Virtual How Survey If you have any questions about this Virtual How please email brian.voellmecke@trinitylifesciences.com....
Available On Demand
...with 27 Chief Commercial Officers at pre-commercial and emerging companies to understand how the biopharma industry is addressing this significant challenge. Key Webinar Topics: Successful hiring practices at pre-commercial and...
...in government healthcare expenditure and medical insurance subsidies in the future. As such, the Chinese government has acknowledged the important role of multi-national companies to drive innovation as seen in...
...therapies in recent years, and many have been commercialized by emerging biopharma companies launching for the first time. For many of these emerging biopharma companies, optimizing commercial launch spend is...
Available On Demand
...tool-built by experts to support smart, efficient launch planning: Create customized roadmaps and detailed launch plans Enable workflow automation, customizable visualizations and streamlined cross-functional project management Accelerate communication, transparency, collaboration...
Available On Demand
...exploring the implications for currently marketed Medicare Part B and Part D therapies, as well as for future product launches. Don’t miss your chance to gain an in-depth understanding of...
...currently comprised of ethnic and racial minorities, quite often only 5 to 10% of clinical trial participants represent any minority population. The disparity is striking and can also leave care...
